1. Home
  2. FCUV vs VIVS Comparison

FCUV vs VIVS Comparison

Compare FCUV & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Focus Universal Inc.

FCUV

Focus Universal Inc.

HOLD

Current Price

$5.06

Market Cap

4.9M

Sector

Industrials

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

BUY

Current Price

$2.08

Market Cap

5.2M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
FCUV
VIVS
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FCUV
VIVS
Price
$5.06
$2.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.6K
4.9M
Earning Date
03-26-2026
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$387,457.00
$142,000.00
Revenue This Year
N/A
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.39
52 Week Low
$4.91
$1.41
52 Week High
$61.40
$21.96

Technical Indicators

Market Signals
Indicator
FCUV
VIVS
Relative Strength Index (RSI) 74.17 47.82
Support Level $4.91 $1.81
Resistance Level $6.19 $2.89
Average True Range (ATR) 0.86 0.34
MACD 0.57 -0.04
Stochastic Oscillator 36.50 17.16

Price Performance

Historical Comparison
FCUV
VIVS

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: